13/11/2019 - 09:15

MGC lands first Aussie Gov grant

13/11/2019 - 09:15

Bookmark

Upgrade your subscription to use this feature.

MGC Pharmaceuticals has received a Government grant to support its research and development work relating to phyto-cannabinoid derived medicines to treat the symptoms of dementia and Alzheimer's. According to the Australian Bureau of Statistics, dementia is the second leading cause of death for Australians, which means that MGC will have a sizeable addressable market if it’s cannabis-based medicinal products can have an impact on this debilitating disease.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options